Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Cancerologie de l'Ouest
This is a prospective single-center dosimetry study that exhaustively included brain tumor and prostate cancer patients treated at the ICO Site d'Angers by external radiotherapy and prior to which they were given an MRI and a simulation CT in treatment position over a 12-month period.
For patients who agree to participate in the study, CT-synthetic images will be generated from the MRI images by automatic assignment of densities (5 classes).
Reference CT images from CT and synthetic CT images from MRI will be available for comparison for all eligible patients.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Age ≥ 18 years old
2. Male or Female with a (primary) brain tumour or Male with cancer and localized (non-metastatic) prostate cancer
3. Patient having benefited from a planning MRI scan in treatment position performed according to the new acquisition modalities (allowing the generation of CT-synthetics by automatic assignment of densities) performed since January 2020 and a planning scanner in treatment position prior to external radiotherapy.